Medical Devices Startups

Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation. The company serves oncology clinics, trial matching networks, and quality reporting teams.

4 investors

Truvian builds an on-site blood diagnostics platform that combines clinical chemistry, immunoassay, and hematology testing in a single compact instrument. It targets routine blood testing for consumers as an alternative to traditional off-site labs, pursuing a staged FDA clearance strategy for its assays.

4 investors

A company focused on developing clinical treatments aimed at improving patient outcomes.

4 investors

Ultima Genomics develops genomic sequencing technology to scale omics information for advances in biology and human health improvements.

4 investors

Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.

4 investors

VGS (Vascular Graft Solutions) develops medical technologies for coronary artery bypass surgery (CABG), including VIOLA for clampless proximal aortic anastomosis and VEST, an external support device for vein grafts. Its products aim to improve vein graft longevity and reduce procedure-related neurological complications for cardiac surgery patients and healthcare providers.

4 investors

Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies. The company focuses on scalable, sensor-based medical devices for healthcare applications.

4 investors

Velorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.

4 investors

Vena Vitals develops a noninvasive, continuous blood pressure monitoring device using patented sensor technology placed on the skin over an artery. The system targets anesthesiologists, sleep physicians, and hospitals for intraoperative, sleep disorder, and clinical monitoring applications.

4 investors

Vesteck develops medical device technology in the cardiovascular/endovascular space. The investors page presents an investor presentation and a section on the company's backers but does not name specific individuals or firms.

4 investors

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.

4 investors

Virgo develops foundation models and AI software for endoscopy, enabling gastroenterologists to analyze colonoscopy videos for diagnostic scoring, patient outcome prediction, and clinical trial acceleration. The platform serves healthcare providers, researchers, and clinical trial sponsors in gastroenterology.

4 investors

Virtonomy builds v-Patients, a digital twin and simulation platform that lets medical device developers test devices in virtual patient cohorts based on real clinical data, covering products such as heart valves, stents, catheters, and occluders. The platform supports the full device development lifecycle including anatomical simulations, structural and fluid dynamics analysis, and regulatory reporting accepted as digital evidence by the FDA and EU regulatory bodies.

4 investors

Vitara Biomedical develops medical technology for the care of extremely premature newborns. The company is rooted in neonatology research from Children's Hospital of Philadelphia.

4 investors

Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types. The company adopts a capital-efficient approach to advance novel cancer therapeutics, with potential applications also in fibrotic disease.

4 investors

Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs. The company operates a bioprinting facility in Houston, Texas focused on advancing technologies for tissue engineering and bioprinted constructs.

4 investors

Wandercraft builds self-balancing humanoid exoskeletons and autonomous industrial humanoid robots, combining AI with high-performance hardware. Its products include Calvin, an autonomous industrial humanoid for factories and logistics centers, and Eve, a crutch-free personal exoskeleton for people with mobility impairments to stand and walk at home, plus exoskeletons for gait rehabilitation in hospitals.

4 investors

Wenzel Spine is a medical technology company that develops and manufactures products for minimally invasive spine surgery, including stand-alone spine fusion devices. It serves surgeons and their patients across the healthcare system, operating in the spine/orthopaedics medical device industry.

4 investors

Wheeler Bio operates as a contract development and manufacturing organization (CDMO) for biomanufacturing, providing development and manufacturing expertise for biologics therapeutics.

4 investors

Windgap Medical designs autoinjector devices for delivering complex drugs and combination products, including systems for reconstituting lyophilized or powdered compounds, sequential delivery of two liquid therapies, high-viscosity medications, and large-volume injections. It serves biopharmaceutical companies developing drug-device combination products.

4 investors

World Class Health operates a Center of Excellence platform that coordinates specialty surgical and procedural care for self-insured employers. The platform combines transparent pricing, clinical case management by nurses, and AI-driven predictive intelligence to route employees to high-quality providers while reducing surgical costs across orthopedics, spine, cardiac, and other specialties.

4 investors

Allotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.

4 investors

X-Therma develops a proprietary peptoid-based technology that inhibits ice crystal formation to enable long-term sub-zero preservation and transport of cells, tissues, organs, and other biologics. Its products, including the XT-ViVo preservation solution and TimeSeal organ transport device, target organ and biologic preservation for transplantation.

4 investors

XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage. The company's lead program, XC001, targets refractory angina in patients with limited treatment options.

4 investors